Bepridil for chronic stable angina pectoris: Results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients
Authors:
- DiBianco RobertDRDiBianco Robert
- Alpert JosephAJAlpert Joseph
- Richard J. KatzRKRichard J. Katz
- Spann JamesSJSpann James
- Chesler ElliotCEChesler Elliot
- Donald P. FerriDFDonald P. Ferri
- Louis J. LarcaLLLouis J. Larca
- Costello Rebecca BortzCBCostello Rebecca Bortz
- Joel M. GoreJGJoel M. Gore
- Myron J. EisenmanMEMyron J. Eisenman
- 1 January 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (1) , 35-41
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Calcium channel blockade as primary therapy for stable angina pectorisThe American Journal of Cardiology, 1982
- The current status of the mechanism of the calcium channel antagonistsProgress in Cardiovascular Diseases, 1982
- Clinical pharmacology of slow channel blocking agentsProgress in Cardiovascular Diseases, 1982
- Electrophysiologic and hemodynamic effects of slow-channel blocking drugsProgress in Cardiovascular Diseases, 1982
- Comparison of the antianginal efficacy of acebutolol and propranolol. A multicenter, randomized, double-blind placebo-controlled study.Circulation, 1982
- Efficacy of diltiazem in angina on effort: A multicenter trialThe American Journal of Cardiology, 1982
- Comparison of Nadolol, A New Long-Acting Beta-Receptor Blocking Agent, and Placebo in the Treatment of Stable Angina PectorisChest, 1981
- Effects of bepridil on mitochondrial atpase reactionsBiochemical Pharmacology, 1980
- Antidysrhythmic and Electrophysiological Effects of a New Antianginal Agent, BepridilJournal of Cardiovascular Pharmacology, 1980
- Importance of the Design of an Exercise Protocol in the Evaluation of Patients with Angina PectorisCirculation, 1971